Xuezhong Yu to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Xuezhong Yu has written about Xenograft Model Antitumor Assays.
Connection Strength
0.276
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.141
-
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A. 2018 02 13; 115(7):1582-1587.
Score: 0.134